Guidance for industry : S7B nonclinical evaluation of the potential for delayed ventricular repolarization (QT Interval Prolongation) by human pharmaceuticals.
| Corporate Authors: | , , |
|---|---|
| Format: | Government Document Conference Proceeding eBook |
| Language: | English |
| Published: |
Rockville, MD :
U.S. Dept. of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research : Center for Biologics Evaluation and Research,
[2005]
|
| Subjects: | |
| Online Access: | https://purl.fdlp.gov/GPO/LPS113878 |
Internet
https://purl.fdlp.gov/GPO/LPS113878Available Online
| Call Number: |
HE 20.4702:N 73/2 |
|
|---|---|---|
| Call Number | Status | Get It |
| HE 20.4702:N 73/2 | Available | |